美国制药企业药品患者援助项目的发展现状与实施方式

Development Status and Implementation Methods of Pharmaceutical Companies'Patient Assistance Programs in the USA

采用文献研究和案例研究法,分析美国制药企业实施的患者援助项目的发展现状和实施方式,为推动我国药品患者援助项目的发展和促进我国多层次医疗保障制度体系的协同发展提供参考。美国制药企业通常将许多品种“打包”成一个项目运营,援助药品数量庞大,疾病覆盖领域广泛,已形成了一套成熟的实施方式,援助方案和宣传形式多样,为没有处方药保险或是处方药保险覆盖范围不足的患者提供了一道安全网。建议我国制药企业开展多样化的患者援助项目、加大项目宣传力度,以推进患者援助项目的实施,从而发挥慈善捐赠作为医疗保障制度体系的补充作用,促进我国多层次医疗保障制度体系协同发展。

Through literature research and case study,the development status and implementation methods of pharmaceutical companies'patient assistance programs in the USA were sorted out to provide recommendations of the development of China's patient assistance programs,and to promote the coordinated development of China's multi-level medical security system.A typical patient assistance program in the USA concluded many drugs covered a wide range of diseases.The patient assistance programs in the USA have formed a mature and diverse system of implementation and advertising.The programs provide a safety net for patients who do not have prescription drug insurance or have insufficient coverage of prescription drug insurance.It is recommended Chinese pharmaceutical companies to develop their own patient assistance programs.It will help to complete the medical security system and promote the coordinated development of China's medical security system.